Rat cytomegalovirus infection depletes MHC II in bone marrow derived dendritic cells

Virology

Volumn 388, Issue 1, 2009, Pages 78-90

  Baca Jones, Carmen C ^a,b   Kreklywich, Craig N ^a   Messaoudi, Ilhem ^a,b   Vomaske, Jennifer ^a,b   McCartney, Erin ^a,b   Orloff, Susan L ^a,b,c   Nelson, Jay A ^a,b   Streblow, Daniel N ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c PORTLAND VA MEDICAL CENTER   (United States)

Author keywords

Antigen presentation processing; Cytomegalovirus; Dendritic cells; MHC; Viral

Indexed keywords

GENE PRODUCT; GREEN FLUORESCENT PROTEIN; INTERLEUKIN 10; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROTEASOME INHIBITOR; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL CELL CULTURE; ANTIGEN PRESENTING CELL; ARTICLE; BONE MARROW CELL; CELL SURFACE; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DENDRITIC CELL; DOWN REGULATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; VIRUS GENE;

ANIMALS; BONE MARROW CELLS; CYTOMEGALOVIRUS INFECTIONS; DENDRITIC CELLS; DOWN-REGULATION; GENE EXPRESSION REGULATION; GENES, MHC CLASS I; GENES, MHC CLASS II; RATS;

CYTOMEGALOVIRUS; MURID HERPESVIRUS 2; RATTUS; RED CLOVER MOTTLE VIRUS;

EID: 67349114276     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2009.02.050     Document Type: Article

References (45)

1. Ahn K., Angulo A., Ghazal P., Peterson P.A., Yang Y., and Fruh K. Human cytomegalovirus inhibits antigen presentation by a sequential multistep process. Proc. Natl. Acad. Sci. U.S.A. 93 20 (1996) 10990-10995
2. Andrews D.M., Andoniou C.E., Granucci F., Ricciardi-Castagnoli P., and Degli-Esposti M.A. Infection of dendritic cells by murine cytomegalovirus induces functional paralysis. Nat. Immunol 2 11 (2001) 1077-1084
3. Cebulla C.M., Miller D.M., Zhang Y., Rahill B.M., Zimmerman P., Robinson J.M., and Sedmak D.D. Human cytomegalovirus disrupts constitutive MHC class II expression. J. Immunol. 169 1 (2002) 167-176
4. Chang W.L., Baumgarth N., Yu D., and Barry P.A. Human cytomegalovirus-encoded interleukin-10 homolog inhibits maturation of dendritic cells and alters their functionality. J. Virol. 78 16 (2004) 8720-8731
5. Dunn W., Chou C., Li H., Hai R., Patterson D., Stolc V., Zhu H., and Liu F. Functional profiling of a human cytomegalovirus genome. Proc. Natl. Acad. Sci. U.S.A. 100 24 (2003) 14223-14228
6. Fish K.N., Soderberg-Naucler C., Mills L.K., Stenglein S., and Nelson J.A. Human cytomegalovirus persistently infects aortic endothelial cells. J. Virol. 72 7 (1998) 5661-5668
7. Frascaroli G., Varani S., Mastroianni A., Britton S., Gibellini D., Rossini G., Landini M.P., and Soderberg-Naucler C. Dendritic cell function in cytomegalovirus-infected patients with mononucleosis. J. Leukoc. Biol. 79 5 (2006) 932-940
8. Hassink G.C., Duijvestijn-van Dam J.G., Koppers-Lalic D., van Gaans-van den Brink J., van Leeuwen D., Vink C., Bruggeman C.A., and Wiertz E.J. Rat cytomegalovirus induces a temporal downregulation of major histocompatibility complex class I cell surface expression. Viral Immunol. 18 4 (2005) 607-615
9. Hegde N.R., Tomazin R.A., Wisner T.W., Dunn C., Boname J.M., Lewinsohn D.M., and Johnson D.C. Inhibition of HLA-DR assembly, transport, and loading by human cytomegalovirus glycoprotein US3: a novel mechanism for evading major histocompatibility complex class II antigen presentation. J. Virol. 76 21 (2002) 10929-10941
10. Hegde N.R., Dunn C., Lewinsohn D.M., Jarvis M.A., Nelson J.A., and Johnson D.C. Endogenous human cytomegalovirus gB is presented efficiently by MHC class II molecules to CD4+ CTL. J. Exp. Med. 202 8 (2005) 1109-1119
11. Kavanagh D.G., Gold M.C., Wagner M., Koszinowski U.H., and Hill A.B. The multiple immune-evasion genes of murine cytomegalovirus are not redundant: m4 and m152 inhibit antigen presentation in a complementary and cooperative fashion. J. Exp. Med. 194 7 (2001) 967-978
12. Kavanagh D.G., Koszinowski U.H., and Hill A.B. The murine cytomegalovirus immune evasion protein m4/gp34 forms biochemically distinct complexes with class I MHC at the cell surface and in a pre-Golgi compartment. J. Immunol. 167 7 (2001) 3894-3902
13. Kleijnen M.F., Huppa J.B., Lucin P., Mukherjee S., Farrell H., Campbell A.E., Koszinowski U.H., Hill A.B., and Ploegh H.L. A mouse cytomegalovirus glycoprotein, gp34, forms a complex with folded class I MHC molecules in the ER which is not retained but is transported to the cell surface. EMBO J. 16 4 (1997) 685-694
14. Kotenko S.V., Saccani S., Izotova L.S., Mirochnitchenko O.V., and Pestka S. Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10). Proc. Natl. Acad. Sci. U.S.A. 97 4 (2000) 1695-1700
15. Kuchroo V.K., Das M.P., Brown J.A., Ranger A.M., Zamvil S.S., Sobel R.A., Weiner H.L., Nabavi N., and Glimcher L.H. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80 5 (1995) 707-718
16. Lang T.J., Nguyen P., Peach R., Gause W.C., and Via C.S. In vivo CD86 blockade inhibits CD4+ T cell activation, whereas CD80 blockade potentiates CD8+ T cell activation and CTL effector function. J. Immunol. 168 8 (2002) 3786-3792
17. Lilley B.N., and Ploegh H.L. Viral modulation of antigen presentation: manipulation of cellular targets in the ER and beyond. Immunol. Rev. 207 (2005) 126-144
18. Liu T., Khanna K.M., Chen X., Fink D.J., and Hendricks R.L. CD8(+) T cells can block herpes simplex virus type 1 (HSV-1) reactivation from latency in sensory neurons. J. Exp. Med. 191 9 (2000) 1459-1466
19. Lockridge K.M., Sequar G., Zhou S.S., Yue Y., Mandell C.P., and Barry P.A. Pathogenesis of experimental rhesus cytomegalovirus infection. J. Virol. 73 11 (1999) 9576-9583
20. Lockridge K.M., Zhou S.S., Kravitz R.H., Johnson J.L., Sawai E.T., Blewett E.L., and Barry P.A. Primate cytomegaloviruses encode and express an IL-10-like protein. Virology 268 2 (2000) 272-280
21. Loewendorf A., Kruger C., Borst E.M., Wagner M., Just U., and Messerle M. Identification of a mouse cytomegalovirus gene selectively targeting CD86 expression on antigen-presenting cells. J. Virol. 78 23 (2004) 13062-13071
22. Mathys S., Schroeder T., Ellwart J., Koszinowski U.H., Messerle M., and Just U. Dendritic cells under influence of mouse cytomegalovirus have a physiologic dual role: to initiate and to restrict T cell activation. J. Infect. Dis. 187 6 (2003) 988-999
23. McLaughlin K., Wu C., Fick G., Muirhead N., Hollomby D., and Jevnikar A. Cytomegalovirus seromismatching increases the risk of acute renal allograft rejection. Transplantation 74 6 (2002) 813-816
24. Michelson S. Interaction of human cytomegalovirus with monocytes/macrophages: a love-hate relationship. Pathol. Biol. (Paris) 45 2 (1997) 146-158
25. Mintern J.D., Klemm E.J., Wagner M., Paquet M.E., Napier M.D., Kim Y.M., Koszinowski U.H., and Ploegh H.L. Viral interference with B7-1 costimulation: a new role for murine cytomegalovirus fc receptor-1. J. Immunol. 177 12 (2006) 8422-8431
26. Mocarski E.S. Cytomegaloviruses and their replication. In: Fields B.N. (Ed). Virology. 4th ed. Vol. 2 (2001), Lippincott-Raven, Philadelphia 2629-2673 2 vols
27. Mocarski Jr. E.S. Immunomodulation by cytomegaloviruses: manipulative strategies beyond evasion. Trends Microbiol. 10 7 (2002) 332-339
28. Moutaftsi M., Mehl A.M., Borysiewicz L.K., and Tabi Z. Human cytomegalovirus inhibits maturation and impairs function of monocyte-derived dendritic cells. Blood 99 8 (2002) 2913-2921
29. Muthana M., Fairburn B., Mirza S., Slack L.K., and Pockley A.G. Systematic evaluation of the conditions required for the generation of immature rat bone marrow-derived dendritic cells and their phenotypic and functional characterization. J. Immunol. Methods 294 1-2 (2004) 165-179
30. Nordoy I., Rollag H., Lien E., Sindre H., Degre M., Aukrust P., Froland S.S., and Muller F. Cytomegalovirus infection induces production of human interleukin-10 in macrophages. Eur. J. Clin. Microbiol. Infect. Dis. 22 12 (2003) 737-741
31. Ochando J.C., Homma C., Yang Y., Hidalgo A., Garin A., Tacke F., Angeli V., Li Y., Boros P., Ding Y., Jessberger R., Trinchieri G., Lira S.A., Randolph G.J., and Bromberg J.S. Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts. Nat. Immunol. 7 6 (2006) 652-662
32. Odeberg J., Plachter B., Branden L., and Soderberg-Naucler C. Human cytomegalovirus protein pp65 mediates accumulation of HLA-DR in lysosomes and destruction of the HLA-DR alpha-chain. Blood 101 12 (2003) 4870-4877
33. Odeberg J., and Soderberg-Naucler C. Reduced expression of HLA class II molecules and Iinterleukin-10- and transforming growth factor beta1-independent suppression of T-cell proliferation in human cytomegalovirus-infected macrophage cultures. J. Virol. 75 11 (2001) 5174-5181
34. Orloff S.L., Streblow D.N., Soderberg-Naucler C., Yin Q., Kreklywich C., Corless C.L., Smith P.A., Loomis C.B., Mills L.K., Cook J.W., Bruggeman C.A., Nelson J.A., and Wagner C.R. Elimination of donor-specific alloreactivity prevents cytomegalovirus-accelerated chronic rejection in rat small bowel and heart transplants. Transplantation 73 5 (2002) 679-688
35. Pinto A.K., Munks M.W., Koszinowski U.H., and Hill A.B. Coordinated function of murine cytomegalovirus genes completely inhibits CTL lysis. J. Immunol. 177 5 (2006) 3225-3234
36. Raftery M.J., Schwab M., Eibert S.M., Samstag Y., Walczak H., and Schonrich G. Targeting the function of mature dendritic cells by human cytomegalovirus: a multilayered viral defense strategy. Immunity 15 6 (2001) 997-1009
37. Raftery M.J., Wieland D., Gronewald S., Kraus A.A., Giese T., and Schonrich G. Shaping phenotype, function, and survival of dendritic cells by cytomegalovirus-encoded IL-10. J. Immunol. 173 5 (2004) 3383-3391
38. Redpath S., Angulo A., Gascoigne N.R., and Ghazal P. Murine cytomegalovirus infection down-regulates MHC class II expression on macrophages by induction of IL-10. J. Immunol. 162 11 (1999) 6701-6707
39. Reusch U., Muranyi W., Lucin P., Burgert H.G., Hengel H., and Koszinowski U.H. A cytomegalovirus glycoprotein re-routes MHC class I complexes to lysosomes for degradation. EMBO J. 18 4 (1999) 1081-1091
40. Spencer J.V., Lockridge K.M., Barry P.A., Lin G., Tsang M., Penfold M.E., and Schall T.J. Potent immunosuppressive activities of cytomegalovirus-encoded interleukin-10. J. Virol. 76 3 (2002) 1285-1292
41. Tomazin R., Boname J., Hegde N.R., Lewinsohn D.M., Altschuler Y., Jones T.R., Cresswell P., Nelson J.A., Riddell S.R., and Johnson D.C. Cytomegalovirus US2 destroys two components of the MHC class II pathway, preventing recognition by CD4+ T cells. Nat. Med. 5 9 (1999) 1039-1043
42. Varani S., Frascaroli G., Gibellini D., Potena L., Lazzarotto T., Lemoli R.M., Magelli C., Soderberg-Naucler C., and Landini M.P. Impaired dendritic cell immunophenotype and function in heart transplant patients undergoing active cytomegalovirus infection. Transplantation 79 2 (2005) 219-227
43. Varani S., Frascaroli G., Homman-Loudiyi M., Feld S., Landini M.P., and Soderberg-Naucler C. Human cytomegalovirus inhibits the migration of immature dendritic cells by down-regulating cell-surface CCR1 and CCR5. J. Leukoc. Biol. 77 2 (2005) 219-228
44. Ziegler H., Muranyi W., Burgert H.G., Kremmer E., and Koszinowski U.H. The luminal part of the murine cytomegalovirus glycoprotein gp40 catalyzes the retention of MHC class I molecules. EMBO J. 19 5 (2000) 870-881
45. Ziegler H., Thale R., Lucin P., Muranyi W., Flohr T., Hengel H., Farrell H., Rawlinson W., and Koszinowski U.H. A mouse cytomegalovirus glycoprotein retains MHC class I complexes in the ERGIC/cis-Golgi compartments. Immunity 6 1 (1997) 57-66